Lv41
542 积分 2023-09-06 加入
Mechanisms regulating PD-L1 expression in cancers and associated opportunities for novel small-molecule therapeutics
2天前
已完结
Emerging evidence for adapting radiotherapy to immunotherapy
3天前
已完结
A new strategy for immunotherapy of microsatellite‐stable (MSS)‐type advanced colorectal cancer: Multi‐pathway combination therapy with PD‐1/PD‐L1 inhibitors
9天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
28天前
已完结
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
1个月前
已完结
Discovery of Daclatasvir as a potential PD-L1 inhibitor from drug repurposing
4个月前
已完结
LW-213 induces immunogenic tumor cell death via ER stress mediated by lysosomal TRPML1
4个月前
已完结
Allosteric SHP2 inhibition enhances regorafenib's effectiveness in colorectal cancer treatment
4个月前
已完结
Targeting SHP2 reverses BRAF inhibitor tolerance in anaplastic thyroid carcinoma
5个月前
已关闭
ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4
5个月前
已完结
皖公网安备34019202002308
